#USA #Marlborough #Boston Scientific #investor conference #Healthcare Innovator

Boston Scientific Prepares for Upcoming Investor Conferences

Boston Scientific Corporation (NYSE: BSX), a global leader in medical technology, has announced its participation in two significant investor conferences to be held in late 2025. These events are aimed at providing insights into the company's innovative approaches in healthcare and their impact on patient treatments.

Event Overview

The first of the two conferences will take place on November 18, 2025. During this event, Dr. Kenneth Stein, who is the Senior Vice President and Global Chief Medical Officer of Boston Scientific, along with Lauren Tengler, Vice President of Investor Relations, will engage in a 30-minute question-and-answer session. This session will be a key opportunity for analysts and investors to gather insights directly from senior executives on the company's vision and strategy. The session will commence at approximately 8:00 a.m. ET and will be part of Wolfe Research's 7th Annual Healthcare Conference.

Shortly after, on December 2, 2025, the company will participate in Citi's 2025 Global Healthcare Conference. This event will feature a 40-minute question-and-answer segment with Joe Fitzgerald, the Executive Vice President and Group President of Cardiology, along with Dr. Janar Sathananthan, Chief Medical Officer for Interventional Cardiology Therapies, and again, Lauren Tengler representing Investor Relations. This session will start around 9:00 a.m. ET, diving deeper into Boston Scientific's advancements in cardiac care and overall healthcare solutions.

Accessing the Webcast

For those unable to attend the live events, Boston Scientific will provide access to a live webcast for both sessions. Interested parties can view the events and subsequent replays on the official Boston Scientific investor relations website: Boston Scientific Investor Relations. The replay is expected to be available roughly an hour after the event concludes, allowing investors and analysts to catch up on insights missed during the live sessions.

Company Background

Boston Scientific has a storied history of over 45 years in the healthcare industry, dedicated to transforming lives through innovative medical technologies. The company’s portfolio includes a range of high-performance solutions that address various unmet medical needs across multiple specialties, including cardiovascular, respiratory, digestive, oncological, neurological, and urological conditions. Their commitment to advancing science for life continues to drive their ongoing efforts to reduce the cost of healthcare while improving patient outcomes.

For more information on Boston Scientific's extensive range of products and innovations, visit their official website or follow their updates on LinkedIn.

Conclusion

The upcoming conferences present a compelling opportunity for Boston Scientific to further highlight its role as a leader in medical technology and innovation. Investors and analysts are encouraged to participate either in-person or via webcast to gain valuable insights into the future direction of the company, its product development strategies, and its overall impact on global healthcare.

For any media inquiries, please reach out to Emily Anderson from Media Relations at +1 (617) 515-2000 or Lauren Tengler in Investor Relations at +1 (508) 683-4479.